Regarding the evidence-based use of micronized progesterone

Regarding the evidence-based use of micronized progesterone

A. D. Makatsariya, G. C. Di Renzo, G. Rizzo

An issue of habitual miscarriage poses a high social importance especially during COVID-19 pandemic. Meanwhile, healthcare workers faced a mass media campaign against using micronized progesterone upon habitual miscarriage, which, as viewed by publication authors, displays signs of prejudiced data manipulation and may disorient practitioners. Authors of published letter provide objective information on accumulated data regarding gestagens efficacy and safety. They invoke healthcare professionals to make decisions deserving independent primary source trust presented by original scientific papers published in peer-reviewed journals, clinical recommendations proposed by professional medical communities as well as treatment standards and protocols.

2020

progesterone, evidence base, dydrogesterone, gestagens, habitual miscarriage

10.18370/2309-4117.2020.55.105-108

Reproduktivnaâ Èndokrinologiâ

Publishing House TRILIST

Gynecology and obstetrics